Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $336,775,907.87
- Aug. 5, 2022
- John Maraganore
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 5, 2022 | EVP | 1,841 | $218.16 | Sell | $401,632.56 | |
Aug. 3, 2022 | EVP | 1,754 | $210.00 | Sell | $368,340.00 | |
July 5, 2022 | EVP | 1,754 | $150.00 | Sell | $263,100.00 | |
April 1, 2022 | Director | 15,000 | $170.69 | Sell | $2,560,350.00 | |
Dec. 23, 2021 | Insider | 2,879 | $190.93 | Sell | $549,687.47 | |
Nov. 12, 2021 | CEO | 33,978 | $171.52 | Sell | $5,827,906.56 | |
Aug. 13, 2021 | CEO | 33,979 | $199.78 | Sell | $6,788,324.62 | |
Aug. 6, 2021 | COO | 53,064 | $199.00 | Sell | $10,559,736.00 | |
Aug. 5, 2021 | EVP | 10,000 | $188.95 | Sell | $1,889,500.00 | |
July 12, 2021 | EVP | 6,812 | $178.96 | Sell | $1,219,075.52 | |
June 18, 2021 | Insider | 14,708 | $175.00 | Sell | $2,573,900.00 | |
June 9, 2021 | EVP | 1,734 | $154.00 | Sell | $267,036.00 | |
May 13, 2021 | CEO | 33,979 | $130.78 | Sell | $4,443,773.62 | |
April 21, 2021 | Insider | 2,732 | $136.95 | Sell | $374,147.40 | |
April 19, 2021 | Insider | 3,706 | $137.67 | Sell | $510,205.02 | |
Jan. 12, 2021 | COO | 3,125 | $161.00 | Sell | $503,125.00 | |
Jan. 12, 2021 | EVP | 14,941 | $160.20 | Sell | $2,393,548.20 | |
Dec. 18, 2020 | Director | 15,000 | $140.00 | Sell | $2,100,000.00 | |
Nov. 25, 2020 | Director | 30,000 | $124.89 | Sell | $3,746,700.00 | |
Sept. 29, 2020 | Insider | 971 | $140.00 | Sell | $135,940.00 | |
Sept. 9, 2020 | President | 44,530 | $123.23 | Sell | $5,487,431.90 | |
Aug. 20, 2020 | CEO | 34,765 | $136.13 | Sell | $4,732,559.45 | |
July 13, 2020 | EVP | 47,250 | $160.67 | Sell | $7,591,657.50 | |
July 9, 2020 | COO | 11,236 | $161.00 | Sell | $1,808,996.00 | |
July 7, 2020 | President | 22,265 | $159.99 | Sell | $3,562,177.35 | |
May 20, 2020 | CEO | 34,765 | $143.22 | Sell | $4,979,043.30 | |
May 6, 2020 | President | 22,265 | $149.99 | Sell | $3,339,527.35 | |
May 5, 2020 | COO | 7,811 | $140.00 | Sell | $1,093,540.00 | |
April 20, 2020 | Insider | 21,971 | $140.00 | Sell | $3,075,940.00 | |
April 20, 2020 | EVP | 10,000 | $139.00 | Sell | $1,390,000.00 | |
Feb. 20, 2020 | CEO | 34,765 | $131.85 | Sell | $4,583,765.25 | |
Feb. 10, 2020 | COO | 9,892 | $130.00 | Sell | $1,285,960.00 | |
Feb. 10, 2020 | Director | 30,000 | $130.00 | Sell | $3,900,000.00 | |
Feb. 7, 2020 | COO | 6,250 | $123.90 | Sell | $774,375.00 | |
Feb. 7, 2020 | Insider | 23,708 | $125.00 | Sell | $2,963,500.00 | |
Jan. 29, 2020 | EVP | 6,337 | $119.00 | Sell | $754,103.00 | |
Jan. 27, 2020 | EVP | 41,037 | $117.70 | Sell | $4,830,054.90 | |
Nov. 20, 2019 | COO | 8,404 | $105.00 | Sell | $882,420.00 | |
Nov. 20, 2019 | Director | 75,000 | $100.00 | Sell | $7,500,000.00 | |
Nov. 18, 2019 | Director | 15,000 | $91.71 | Sell | $1,375,650.00 | |
Oct. 22, 2019 | President | 58,913 | $89.99 | Sell | $5,301,580.87 | |
Oct. 14, 2019 | CEO | 49,456 | $79.45 | Sell | $3,929,279.20 | |
May 15, 2019 | CEO | 49,457 | $70.00 | Sell | $3,461,990.00 | |
April 15, 2019 | Director | 15,000 | $88.23 | Sell | $1,323,450.00 | |
Aug. 30, 2018 | COO | 2,500 | $120.00 | Sell | $300,000.00 | |
July 25, 2018 | CEO | 50,000 | $105.39 | Sell | $5,269,500.00 | |
June 20, 2018 | SVP | 1,563 | $105.04 | Sell | $164,177.52 | |
March 26, 2018 | COO | 7,221 | $136.54 | Sell | $985,955.34 | |
March 20, 2018 | SVP | 1,562 | $149.83 | Sell | $234,034.46 | |
March 14, 2018 | President | 38,460 | $143.10 | Sell | $5,503,626.00 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Laurie Keating, Barry E Greene, Yvonne Greenstreet, Michael Mason, Philip A Sharp, Paul Schimmel, Laurence Reid, Steven M Paul, Sanofi, Dennis A Ausiello, Tolga Tanguler, Kevin P Starr, Michael W Bonney, Phillip A Sharp, David-Alexandre C Gros, Kevin P. Starr, David E I Pyott, Marsha Fanucci, Philip A. Sharp, and John Clarke
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on Aug. 5, 2022.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Akshay Vaishnaw with a total value of $12,672,077.40 on March 14, 2018.